Ulcerative colitis with overlap syndrome of autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis: a case report
DOI:
https://doi.org/10.52547/tygz5j66Keywords:
Ulcerative colitis; Primary sclerosing cholangitis; Autoimmune hepatitis; Primary biliary cholangitis; Overlap syndrome.Abstract
We discuss a rare case of autoimmune hepatitis-primary biliary cholangitis/primary sclerosing cholangitis triple overlap syndrome accompanying ulcerative colitis. The patient was a 55-year-old male who was diagnosed with ulcerative colitis 6 years ago. During the follow-up, abnormal liver function was found and overlap syndrome was diagnosed, and glucocorticoid and ursodeoxycholic acid (UDCA) were given combined treatment. In view of the difficulties encountered in the treatment of this case, it is worth discussing together to further improve the level of clinical treatment.
Downloads
References
Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol 2013; 10 :585-95.
Koskinas J, Raptis I, Manika Z, et al. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol 1999; 11 :1421-4.
McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 1998; 93 :777-84.
Ozaslan E, Efe C, Heurgué–Berlot A, et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol 2014; 12: 863-9.
Guerra I, Bujanda L, Castro J, et al. Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study. J Crohns Colitis 2019; 13 :1492-1500．
Chinese Society of Hepatology, Chinese Society of Gastroenterology & Chinese Society of Infectious Diseases. Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015). J Dig Dis 2017; 18 :247-64.
Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of primary sclerosing cholangitis (2015 version). Zhonghua Gan Zang Bing Za Zhi 2016; 24 :14-22.
Polychronopoulou E, Lygoura V, Gatselis NK, et al. Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Rep 2017; 2017 :bcr2017220824.
Christensen B, Micic D, Gibson PR, et al. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther 2018; 47 :753-62.
Downloads
Published
Data Availability Statement
Ulcerative colitis with overlap syndrome of autoimmune hepatitis, prim ary biliary cholangitis, and primary sclerosing cholangitis: a case report
